Take Solutions Ltd

Dematerialisation status and owner update

• Dematerialisation requests processed; certificates accepted/rejected and listed on exchanges.
• Certificates for dematerialisation mutilated and cancelled; depository named as registered owner in records within prescribed timelines.

AGM details

• Date and time: 29 Sep 2026 at 12:00 P.M. IST; mode: VC/OAVM.
• Quorum present; registered office deemed venue.
• Remote e-voting: 26–28 Sep 2026; combined results to stock exchanges and website.

Key resolutions

• Ordinary: adopt standalone financial statements for year ended 31 Mar 2026 and auditors' report.
• Ordinary: adopt consolidated financial statements for year ended 31 Mar 2026 and auditors' report.
• Ordinary: re-appoint Parmeshvar Dhangare (DIN: 11410125) who retires by rotation.
• Ordinary: appoint M/s A. Raghavendra Rao & Associates as Statutory Auditors for five years.
• Ordinary: appoint Hemang Satra & Associates as Secretarial Auditors for five years.

Voting results

• Combined voting results to be submitted to stock exchanges and placed on company website.

Take Limited closes trading window from Thursday, October 01, 2026 till the completion of 48 hours after the declaration of the Unaudited Financial Results for the quarter and half year ending September 30, 2026.

E-voting cut-off and AGM details

• Cut-off date for e-voting eligibility: September 22, 2026.
• AGM scheduled September 29, 2026 at 12:00 P.M. IST via VC/OAVM.
• Remote e-voting available September 26, 2026 09:00 AM to September 28, 2026 05:00 PM IST.
• Eligibility by names in Register of Members/Beneficial Owners as on cut-off date.

Financial snapshot

• Consolidated total income: 6,087.26 Lakhs for FY26.
• Consolidated revenue from operations: 5,418.53 Lakhs in FY26.
• Consolidated PAT: 1,084.91 Lakhs; EPS ₹0.74.
• Net profit margin: 17.8% of total income.
• ROE: 35.0%; ROCE: 15.37%.
• Current ratio: 4.54x; no borrowings.
• Dividends: no dividend declared for FY26.

Strategic pivot

• Take.Health launched in March 2026.
• Unified AI Platform and One Minute Clinic planned.
• Innovation Fund ₹50 million; Anthropic Claude integrated.

Governance

• MD & CFO Sunil Patra appointed 19 May 2026.
• Board: five directors; three independent as of 31 March 2026.
• Name change to TAKE Limited; MOA revised; object clause expanded.

Audit & risk

• Auditors issued qualified opinion on FY26 due to tax asset recoverability.
• Internal controls adequate; going concern affirmed.
• New statutory auditors appointed; appointment ratified.

Capital & liquidity

• Authorized capital ₹50 crore; issued equity ₹14.7934 crore.
• Equity shares: 147.934 million; 99.62% dematerialised.
• Borrowings: nil; no dividend declared FY26.

Subsidiaries & investments

• Navitas LLP and TAKE Ventures Private Limited are group subsidiaries.
• TAKE Ventures is 100% owned.
• Subsidiaries details provided in annual report disclosures.

Outlook & risks

• Outlook anchored on AI-led healthcare; five growth pillars.
• Key risks: technology, regulatory changes, data privacy, competition, talent.
• Strategy emphasizes asset-light platforms and phased capital deployment.

AGM details

• Date/time: Sep 29, 2026 at 12:00 PM IST; VC/OAVM mode; voting cut-off: Sep 22, 2026.

Resolutions to be voted

• Adopt standalone financial statements for the year ended Mar 31, 2026.
• Adopt consolidated financial statements for the year ended Mar 31, 2026.
• Reappoint Parmeshvar Dhangare as Director, retiring by rotation.
• Appoint M/s A. Raghavendra Rao & Associates as Statutory Auditors for five years.
• Appoint Hemang Satra & Associates as Secretarial Auditors for five years.

Director changes

• Parmeshvar Dhangare to be reappointed as Director (retiring by rotation).

Auditors

• Statutory Auditors: M/s A. Raghavendra Rao & Associates for five years (2026-2031).
• Remuneration to be determined by Board.

Secretarial Auditor

• Secretarial Auditor: Hemang Satra & Associates for five years (2025-2030).
• Remuneration to be determined by Board.

Voting status

• Voting results not disclosed in this filing.

Director re-appointment

• Re-appointment of Parmeshvar Dhangare as Non-Executive Non-Independent Director, subject to AGM approval.

Statutory auditor appointment

• Appointment of M/s. A. Raghavendra Rao & Associates as statutory auditors for five years commencing FY 2026-27.

AGM notice

• Notice of the 25th AGM and Board's Report for FY ended 31 March 2026.
• 25th AGM scheduled for Sep 29, 2026 at 12:00 PM via VC/OAVM.

Voting timeline and scrutiny

• Cut-off date for voting eligibility: Sep 22, 2026.
• Remote e-voting opens Sep 26, 2026 at 09:00 and closes Sep 28, 2026 at 17:00.
• Scrutinizer appointed for remote e-voting and AGM: Aarju Agrawal & Associates.

Resolutions and outcome

• Purpose: Special resolution to approve appointment of Sunil Patra as Managing Director.
• Voting method: remote e-voting and postal ballot forms; cut-off date 3 July 2026.
• Outcome: Approved by requisite majority; in favour 34,355,939 votes (99.98%).
• Against votes: 7,301 (0.02%).
• Deemed passed on August 14, 2026.
• MD appointment: Sunil Patra (DIN 11728362) appointed as Managing Director; term not disclosed.